← Back to patent-cliff list
Nor Ursodeoxycholic Acid
Tier C — Watch / tradeNor Ursodeoxycholic Acid
Dr. Falk Pharma GmbH
Originator
2025
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：Cholesterol
Indications (approved)：Non-alcoholic steatohepatitis
Regional status
US
-
EU
Phase III
2018-02-08
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Nor Ursodeoxycholic Acid?
Approved indications include: Non-alcoholic steatohepatitis.
When does the Nor Ursodeoxycholic Acid patent expire?
No public expiry year is available for Nor Ursodeoxycholic Acid yet; this page updates once verified.
How do I get a quote for Nor Ursodeoxycholic Acid intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-01